Literature DB >> 25815130

CD271 as a marker to identify mesenchymal stem cells from diverse sources before culture.

María Álvarez-Viejo1, Yolanda Menéndez-Menéndez1, Jesús Otero-Hernández1.   

Abstract

Mesenchymal stem cells, due to their characteristics are ideal candidates for cellular therapy. Currently, in culture these cells are defined by their adherence to plastic, specific surface antigen expression and multipotent differentiation potential. However, the in vivo identification of mesenchymal stem cells, before culture, is not so well established. Pre-culture identification markers would ensure higher purity than that obtained with selection based on adherence to plastic. Up until now, CD271 has been described as the most specific marker for the characterization and purification of human bone marrow mesenchymal stem cells. This marker has been shown to be specifically expressed by these cells. Thus, CD271 has been proposed as a versatile marker to selectively isolated and expand multipotent mesenchymal stem cells with both immunosuppressive and lymphohematopoietic engraftment-promoting properties. This review focuses on this marker, specifically on identification of mesenchymal stem cells from different tissues. Literature revision suggests that CD271 should not be defined as a universal marker to identify mesenchymal stem cells before culture from different sources. In the case of bone marrow or adipose tissue, CD271 could be considered a quite suitable marker; however this marker seems to be inadequate for the isolation of mesenchymal stem cells from other tissues such as umbilical cord blood or wharton's jelly among others.

Entities:  

Keywords:  Bone marrow; CD271; Low-affinity nerve growth factor receptor; Mesenchymal stem cells; p75

Year:  2015        PMID: 25815130      PMCID: PMC4369502          DOI: 10.4252/wjsc.v7.i2.470

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  60 in total

1.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

2.  Could cord blood be a source of mesenchymal stromal cells for clinical use?

Authors:  C Perdikogianni; H Dimitriou; E Stiakaki; G Martimianaki; M Kalmanti
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

3.  The CD271 expression could be alone for establisher phenotypic marker in Bone Marrow derived mesenchymal stem cells.

Authors:  Edgardo Flores-Torales; Arturo Orozco-Barocio; Oscar R Gonzalez-Ramella; Antonio Carrasco-Yalan; Karlen Gazarian; Silvio Cuneo-Pareto
Journal:  Folia Histochem Cytobiol       Date:  2010-12       Impact factor: 1.698

4.  CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.

Authors:  Selim Kuçi; Zyrafete Kuçi; Hermann Kreyenberg; Erika Deak; Kathrin Pütsch; Sabine Huenecke; Chandrasekhar Amara; Stefanie Koller; Eva Rettinger; Manuel Grez; Ulrike Koehl; Hatixhe Latifi-Pupovci; Reinhard Henschler; Torsten Tonn; Dorothee von Laer; Thomas Klingebiel; Peter Bader
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

5.  Human adipose tissue is a source of multipotent stem cells.

Authors:  Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

6.  The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells.

Authors:  A J Friedenstein; R K Chailakhjan; K S Lalykina
Journal:  Cell Tissue Kinet       Date:  1970-10

7.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood.

Authors:  Wolfgang Wagner; Frederik Wein; Anja Seckinger; Maria Frankhauser; Ute Wirkner; Ulf Krause; Jonathon Blake; Christian Schwager; Volker Eckstein; Wilhelm Ansorge; Anthony D Ho
Journal:  Exp Hematol       Date:  2005-11       Impact factor: 3.084

Review 8.  Human bone marrow mesenchymal stem cells in vivo.

Authors:  E Jones; D McGonagle
Journal:  Rheumatology (Oxford)       Date:  2007-11-06       Impact factor: 7.580

9.  Age-related yield of adipose-derived stem cells bearing the low-affinity nerve growth factor receptor.

Authors:  Raquel Cuevas-Diaz Duran; Maria Teresa González-Garza; Alejandro Cardenas-Lopez; Luis Chavez-Castilla; Delia Elva Cruz-Vega; Jorge E Moreno-Cuevas
Journal:  Stem Cells Int       Date:  2013-11-24       Impact factor: 5.443

Review 10.  Human mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applications.

Authors:  Akaitz Dorronsoro; Jon Fernández-Rueda; Karoline Fechter; Izaskun Ferrin; Juan Manuel Salcedo; Emma Jakobsson; César Trigueros
Journal:  Bone Marrow Res       Date:  2013-09-29
View more
  52 in total

1.  Prospective isolation of resident adult human mesenchymal stem cell population from multiple organs.

Authors:  Yo Mabuchi; Yumi Matsuzaki
Journal:  Int J Hematol       Date:  2015-12-16       Impact factor: 2.490

2.  Osteogenic differentiation of CD271(+) cells from rabbit bone marrow cultured on three phase PCL/TZ-HA bioactive scaffolds: comparative study with mesenchymal stem cells (MSCs).

Authors:  Alessia Colosimo; Cristina Rofani; Elisa Ciraci; Aurelio Salerno; Maria Oliviero; Ernesto Di Maio; Salvatore Iannace; Paolo A Netti; Francesco Velardi; Anna C Berardi
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 3.  Therapeutic Advancement in Neuronal Transdifferentiation of Mesenchymal Stromal Cells for Neurological Disorders.

Authors:  Princy Choudhary; Ayushi Gupta; Sangeeta Singh
Journal:  J Mol Neurosci       Date:  2020-10-13       Impact factor: 3.444

Review 4.  Growth plate skeletal stem cells and their transition from cartilage to bone.

Authors:  Yuki Matsushita; Wanida Ono; Noriaki Ono
Journal:  Bone       Date:  2020-04-07       Impact factor: 4.398

Review 5.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

6.  Evaluation of Autologously Derived Biomaterials and Stem Cells for Bone Tissue Engineering.

Authors:  Paiyz E Mikael; Aleksandra A Golebiowska; Sangamesh G Kumbar; Syam P Nukavarapu
Journal:  Tissue Eng Part A       Date:  2020-06-25       Impact factor: 3.845

7.  Marker Expression of Interstitial Cells in Human Skeletal Muscle: An Immunohistochemical Study.

Authors:  Eva K Hejbøl; Mohammad A Hajjaj; Ole Nielsen; Henrik D Schrøder
Journal:  J Histochem Cytochem       Date:  2019-08-14       Impact factor: 2.479

8.  Downregulation of heat shock protein B8 decreases osteogenic differentiation potential of dental pulp stem cells during in vitro proliferation.

Authors:  M Flanagan; C Li; M A Dietrich; M Richard; S Yao
Journal:  Cell Prolif       Date:  2017-12-20       Impact factor: 6.831

9.  Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.

Authors:  Adam Nowakowski; Katarzyna Drela; Justyna Rozycka; Miroslaw Janowski; Barbara Lukomska
Journal:  Stem Cells Dev       Date:  2016-09-07       Impact factor: 3.272

Review 10.  Skeletal Stem Cells for Bone Development and Repair: Diversity Matters.

Authors:  Yuki Matsushita; Wanida Ono; Noriaki Ono
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.